Skip to content

Medical-device intelligence

QGH: Electroconvulsive Therapy Device For Catatonia, Major Depressive Disorder, And Bipolar Disorder

FDA product code QGH: Electroconvulsive Therapy Device For Catatonia, Major Depressive Disorder, And Bipolar Disorder. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QGH
FDA device name
Electroconvulsive Therapy Device For Catatonia, Major Depressive Disorder, And Bipolar Disorder
Device class
2
Regulation number
882.5940
Medical specialty
Neurology
Review panel
NE

FDA definition

Catatonia or a severe major depressive episode (MDE) associated with major depressive disorder (MDD) or bipolar disorder (BPD) in patients age 13 years and older who are treatment-resistant or who require a rapid response due to the severity of their psychiatric or medical condition.
Explore neurology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

9 clearance records and 0 recall records in the covered releases, across 5 source company names and 1 product codes. Dated history runs from Dec 3, 1984 to Apr 26, 2020.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

9 matching records
Device / recordCompany in FDA recordSourceSource date
MECTA SigmaK192834 · QGHMecta Corporation510(k)Apr 26, 2020FDA decision date
SPECTRUM 5000 Q, 5000Q,M,4000 Q, 4000 M.K965070 · QGHMecta Corp.510(k)Mar 6, 1997FDA decision date
SPECTRUM 5000 Q, 5000 M, 4000 Q, 4000 MK960754 · QGHMecta Corp.510(k)Sep 18, 1996FDA decision date
THYMATRON 2000 ELECTROCONVULSIVE SYSTEMK945120 · QGHSomatics, Inc.510(k)Oct 26, 1995FDA decision date
MF-500, MODIFICATIONK911144 · QGHElcot, Inc.510(k)Oct 18, 1991FDA decision date
ELECTROCONVULSIVE THERAPY DEVICE, MODEL MF-1000K863815 · QGHElcot, Inc.510(k)Jun 2, 1987FDA decision date
ELECTROSHOCK UNIT NEUROLOGY MODEL B-25K860467 · QGHMedcraft Corp.510(k)Nov 10, 1986FDA decision date
MECTA ECT DEVICE MODELS SR & JRK852069 · QGHMecta Corp.510(k)Aug 9, 1985FDA decision date
THYMATRONK843923 · QGHSomatics, Inc.510(k)Dec 3, 1984FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗